Xilio Therapeutics, Inc. (XLO) Dividend History

Company News

• Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

  Xilio Therapeutics announced the closing of a $50.0 million public offering, with the potential for up to $150.0 million in total gross proceeds if all warrants are exercised. The financing was co-led by new investors Coastlands Capital and Frazier Life Sciences, and included participation from Gilead Sciences, Logos Capital, and Samsara BioCapital.

  GlobeNewswire Inc.

  Featured Companies: GILD
• Xilio Therapeutics Announces Proposed Public Offering

  Xilio Therapeutics, a clinical-stage biotechnology company, announced a proposed public offering of pre-funded warrants, Series A, B, and C warrants to purchase shares of common stock. The company plans to use the net proceeds to advance the development of its product candidates and for general corporate purposes.

  Benzinga
• Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat

  Gilead (GILD) reports narrower-than-expected loss in the first quarter. Its sales beat estimates on higher HIV, Oncology and Liver Disease sales.

  Zacks Investment Research

  Featured Companies: ADMA ANIP GILD
• Sizing Your Penny Stocks Position, 3 Tips

  Here's how to size your penny stocks position The post Sizing Your Penny Stocks Position, 3 Tips appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks

  Featured Companies: DNA
• Stocks To Watch: Retail Giants Report, Sono Motors IPO And Rivian Week Two

  Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week

  Seeking Alpha

  Featured Companies: ANET CLX DLB EAT EVGO FIVN FL KSS LOW LVS LZB M MGA PANW RWAY SIG SR SYY TDOC TGT TJX TSN VOYA WDAY WDC WMG WYNN XRT